Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cysteine is a semiessential proteinogenic amino acid and a building block of proteins used throughout the body. It is commonly found as a component of total parenteral nutrition (TPN) to meet nutritional requirements in hospitalized patients and newborns requiring intravenous feeding[3][8]. Cysteine acts as an antioxidant due to its thiol group and serves as a precursor for glutathione synthesis—a key intracellular antioxidant[2][5]. In medicine (notably as N-acetylcysteine), it is used as an antidote for acetaminophen overdose by binding toxic metabolites in the liver[1][2][3]. It also has mucolytic properties and can help break down mucus in respiratory conditions. Cysteine may be essential under certain conditions such as infancy or metabolic disease[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cysteine.